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Individuals who score high in self-reported Intolerance of Uncertainty (IU) display 
difficulties updating threat associations to safe associations. Here we sought to 
determine whether individuals who score high in IU can learn and retain new safety 
associations if given more exposure. We recorded skin conductance response, pupil 
dilation and expectancy ratings during an associative threat learning task with 
acquisition, same-day extinction and next-day extinction phases. Participants (n = 
144) were assigned to either a regular exposure (32 trials of same-day and next-day 
extinction) or extended exposure condition (48 trials of same-day and next-day 
extinction). We failed to replicate previous work showing that IU is associated with 
poorer safety-learning indexed via SCR. We found preliminary evidence for 
promoted safety-retention in individuals with higher Inhibitory IU in the extended 
exposure condition, relative to individuals with higher Inhibitory IU in the regular 
exposure condition, indexed via SCR. These findings further our current 
understanding of the role of IU in safety-learning and -retention, informing models of 
IU and exposure-based treatments.  
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The ability to learn and update threat and safety associations is crucial for  
maintaining health and wellbeing (Milad & Quirk, 2012; Shin & Liberzon, 2009). 
Learning threat associations is adaptive and protects us from potentially dangerous 
situations. However, when a cue ceases to signal threat, it is adaptive to update this 
association. Failure to do so can result in dysfunctional fears that affect quality of life. 
Changes in contingency, such as threat to safety, may not always be obvious; it may 
take a few experiences to recognise that something that once signalled threat may 
now signal safety. Uncertainty about changes in contingency from threat to safety in 
the environment may prolong the learning and retention of new safety associations 
(Bouton, 2002). 
Uncertainty has been identified as an important facet of anxiety and stress 
disorders (Carleton, 2016a, 2016b; Dugas, Buhr, & Ladouceur, 2004; Grupe & 
Nitschke, 2013). Yet, only recently has the role of individual differences in 
Intolerance of Uncertainty (IU) (Freeston, Rhéaume, Letarte, Dugas, & Ladouceur, 
1994), a tendency to find uncertainty aversive, been examined in relation to safety-
learning (Morriss, Christakou, & Van Reekum, 2015, 2016) and safety-retention 
(Dunsmoor, Campese, Ceceli, LeDoux, & Phelps, 2015; Lucas, Luck, & Lipp, 2018). 
More specifically, previous work has shown that higher IU is associated with reduced 
safety-learning, indexed by greater skin conductance responding and pupil dilation to 
cues that no longer signal threat during the late part of same-day extinction (i.e. last 
8 trials) (Morriss, 2019; Morriss et al., 2015; Morriss & van Reekum, 2019). 
Furthermore, high IU is associated with poorer safety-retention, as higher IU 
individuals show larger skin conductance responding to cues that no longer signal 
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threat: (1) during next-day extinction (Dunsmoor et al., 2015), and (2) during same-
day extinction after reinstatement (Lucas et al., 2018). 
Despite these advancements, it is unclear whether individuals who score high 
in IU have a fundamental difficulty with safety-learning and safety-retention or 
whether they simply require more exposure than individuals low in IU i.e. extended 
extinction sessions across a number of days. Given that IU is transdiagnostic 
(Gentes & Ruscio, 2011; McEvoy & Mahoney, 2012) and that current exposure 
therapies are based on associative learning principles (Craske, Treanor, Conway, 
Zbozinek, & Vervliet, 2014), examining the impact of IU upon exposure experience 
may reveal crucial information relevant to anxiety and stress disorders. In particular, 
examining IU in relation to safety-retention across multiple extinction sessions is 
highly relevant due to high rates of relapse in anxiety and stress disorders 
(Bandelow, Michaelis, & Wedekind, 2017). We can speculate that IU may be one of 
the reasons why after treatment some patients with anxiety disorders relapse i.e. 
individuals with higher IU have difficulty retaining safety information. Therefore, 
examining the circumstances under which safety-learning and safety-retention can 
be promoted in individuals with high IU may facilitate new avenues for clinical 
research on the role of IU and exposure-based treatments for anxiety and stress 
disorders (Craske et al., 2014; Knowles & Olatunji, 2018) 
Here we used an associative threat learning task in a relatively large sample 
(n = 144), to assess the relationship between self-reported IU and exposure 
experience on safety-learning and safety-retention. We measured skin conductance 
responses, pupil dilation and expectancy ratings whilst participants underwent threat 
acquisition, same-day extinction and next-day extinction phases. We used an 
aversive sound as an unconditioned stimulus and visual shape stimuli as conditioned 
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stimuli, similar to previous conditioning research including our own (Morriss et al., 
2015; Morriss, Christakou, et al., 2016; Neumann & Waters, 2006). We used a 50% 
reinforcement rate during acquisition to sustain conditioning during extinction (Grady, 
Bowen, Hyde, Totsch, & Knight, 2016; Leonard, 1975). Participants were assigned to 
either a regular exposure (32 trials of same-day and next-day extinction) or extended 
exposure condition (48 trials of same-day and next-day extinction). We matched 
individuals based on self-reported IU to ensure we had an equal balance of IU in 
each condition. 
In the regular exposure condition, participants underwent same-day and next-
day extinction with 32 trials each, similar to the number of trials used in previous 
research on same-day extinction (Dunsmoor et al., 2015; Lucas et al., 2018; Morriss 
et al., 2015; Morriss, Christakou, et al., 2016). In the extended exposure condition, 
participants underwent same-day and next-day extinction with 48 trials each, in line 
with longer extinction sessions used in prior studies i.e 48-60 trials (Rabinak et al., 
2014; Sehlmeyer et al., 2011; Wicking et al., 2016). It has been shown that it is the 
number of trials not the cumulated duration of trials in extinction that determines 
safety-learning success (Golkar, Bellander, & Öhman, 2013). Therefore, differences 
between the regular and extended exposure conditions should be determined by the 
difference in the number of trials only. Notably, on next-day extinction, the 
conditioned response fades more quickly due to re-extinction processes (also known 
as the extinction retention index), therefore less trials are typically used (Lonsdorf, 
Merz, & Fullana, 2019). However, we included more trials in order to compare 
whether safety-learning is improved for individuals high in IU during next-day 
extinction, compared to same-day extinction.  
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We hypothesised that during threat acquisition, we would observe conditioned 
responding, indexed by greater skin conductance responding, pupil dilation and 
expectancy ratings to the learned threat (CS+) versus safety (CS-) cues. The first 
aim was to replicate previous findings regarding safety-learning, safety-retention and 
IU. Based on previous research, we predicted that in the regular exposure condition 
higher IU would be associated with a larger conditioned response to the CS+ vs. CS- 
cues during the late part of same-day extinction (i.e. last 8 CS+/CS- trials) (Morriss, 
2019; Morriss et al., 2015; Morriss, Christakou, et al., 2016; Morriss & van Reekum, 
2019) and the early part of next-day extinction (first 8 CS+/CS- trials) (Dunsmoor et 
al., 2015).  
The proposed study aimed to extend prior findings by examining whether 
more exposure promotes safety-learning and retention in individuals with higher 
levels of IU. The first way we attempted to do this was by including more trials during 
next-day extinction than in previous research. The second way we attempted to do 
this was by evaluating whether more exposure promotes safety-learning and 
retention in individuals with higher levels of IU is by comparing conditions that vary in 
the number of exposure trials across both same-day and next-day extinction. 
Specifically, we evaluated the hypothesis that individuals with higher IU would show 
reduced conditioned responding to the CS+ vs. CS- cues in the extended condition 
relative to the regular condition during: 1. the late part of same-day extinction (i.e. 
last 8 CS+/CS- trials); 2. the early and the late parts of next-day extinction. Lastly, we 
hypothesised that low IU individuals would extinguish similarly regardless of the 
number of exposure trials on same-day and next-day extinction. These hypotheses 
were tentative given the lack of research that has examined the impact of more 
exposure and IU on safety-learning and retention during next-day extinction. 
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In line with our previous work (for discussion see Morriss, Christakou & van 
Reekum, 2016) we tested the specificity of IU effects by controlling for trait anxiety, 
assessed by the State-Trait Inventory for Cognitive and Somatic Anxiety (STICSA: 
Ree, French, MacLeod, & Locke, 2008). We selected the STICSA because it is 
considered a purer measure of anxiety, compared to other trait anxiety measures 
which also feature depressive symptomology (Grös, Antony, Simms, & McCabe, 
2007). 
The experimental protocol and hypotheses were preregistered with the Open 




144 participants were recruited from the University of Reading and local area 
through the use of advertisements and word of mouth (Sex: 86 female, 58 male; M 
age = 23.99 years, SD = 4.42 years, range = 18 – 35 years; Ethnicity: 92 White, 29 
Asian, 4 Middle Eastern/Arab, 2 Black, 2 Mixed, and 15 not specified; Sexual 
Orientation: 104 Heterosexual, 20 Sexual Minorites (lesbian/gay/ 
bisexual/pansexual), 20 not specified). 6 participants did not return for the second 
day of testing and for 2 participants there were technical errors, leaving 136 
participants with day 1 and day 2 data, and 142 participants with day 1 data. 
Participants were recruited if they were between 18-35 years of age. This age 
range was selected on the basis that there may be additional differences in safety-
learning and retention due to age and hormone levels in populations that are under 
or over this range (Lonsdorf & Merz, 2017). No other exclusion criteria were used for 
recruitment. We did not restrict recruitment according to IU score. Participants were 
8 
 
paid £15 in total to remunerate them for their time. Participants received £5 at the 
end of the first day of testing and £10 at the end of the second day of testing. The 
procedure was given ethical approval by the University of Reading Research Ethics 
Committee.  
The experimental data were analysed using multilevel models (MLM), where 
IU and STICSA scores were entered as a continuous predictor variables. MLMs are 
more powerful than repeated measures ANCOVA’s as they can account for missing 
cases (Quené & Van den Bergh, 2004). Despite this, there is no agreed upon 
method for calculating power and estimating sample size for MLM because of the 
complexity of the approach (Peugh, 2010; Snijders, 2005). For this reason, 
appropriate sample sizes were estimated based upon power analyses using and 
ANCOVA.  
The initial power analyses estimated 136 participants. However, we realised 
that it included an incorrect f value. Therefore, we updated the power analyses to the 
following. The sample size of this study was based on a power analysis using the 
average effect size (ᶯ2p = .16) taken from Stimulus x Time x IU interactions for SCR 
magnitude from five previous experiments (4/5 with significant effects of IU)(Morriss, 
Christakou, & Van Reekum, 2015, 2016; Morriss & van Reekum, 2019). The 
following parameters were used: effect size f = 0.43 (converted from ᶯ2p = 0.16), α 
error probability = 0.05, Power (1- error probability) = 0.95, number of groups = 2 
(regular, extended), numerator df = 1, number of covariates = 2 (IU, STICSA). The 
total sample size required was n = 73. Based on the updated power analysis, we 





On the first day of the experiment, participants were informed about the experimental 
procedures. Participants were seated in the testing booth and asked to complete a 
consent form and a set of questionnaires on the computer (see below). One of the 
researchers assigned participants to either condition (regular, extended) based on IU 
score, to ensure an even distribution of IU in each condition (Morriss & van Reekum, 
2018). The other researcher who was responsible for testing the participant was 
blind to condition allocation.  
Participants were asked to wash their hands in water without any soap and 
remove any eye-makeup. Next, physiological sensors were attached to the 
participants’ non-dominant hand and the eyetracker was mounted upon the 
participants’ head. The conditioning task (see “Conditioning task” below for details) 
was presented on a computer, whilst skin conductance, pupil dilation and 
behavioural ratings were recorded. Participants were instructed to: (1) maintain 
attention to the task by looking at the coloured squares and listening to the sounds, 
(2) respond to the expectancy rating scales that follow the end of each block of trials, 
using number keys on the keyboard with their dominant hand and (3) to stay as still 
as possible.  
On the second day (24 hours later), participants received the same 
instructions as in the first day. The same computer and physiological setup was used 
as above. Each testing session took approximately 30 minutes in total. 
 
Conditioning task  
The conditioning task was designed using E-Prime 2.0 software (Psychology 
Software Tools Ltd, Pittsburgh, PA). Visual stimuli were presented at a 75 Hz refresh 
rate on a 21inch colour monitor (DiamondPro, Sony). Participants sat approximately 
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60 cm from the screen. Visual stimuli were blue and yellow squares with visual 
angles of 6.16° × 9.07°. The aversive sound stimulus was presented through 
headphones. The sound consisted of a scream used in our previous experiments 
(Morriss, Saldarini, & Van Reekum, 2019; Morriss & van Reekum, 2019). The 
volume of the sound was standardized across participants by using fixed volume 
settings on the presentation computer and verified by an audiometer prior to each 
session (90 dB). 
The task comprised of three learning phases: threat acquisition, same-day 
extinction (SDE) and next-day extinction (NDE). In acquisition, one of the coloured 
squares (blue or yellow) was paired with the aversive 90 dB sound 50% of the time 
(CS+), whilst the other square (yellow or blue) was presented alone (CS-). 
Conditioning contingencies were counterbalanced, with half of participants receiving 
the blue square paired with the US and the other half of participants receiving the 
yellow square paired with the US. We used a 50% pairing rate to maximize the 
unpredictability of the CS+ / US contingency. During the extinction phases, both the 
blue and yellow squares were presented in the absence of the US. Participants did 
not receive contingency instructions about any of the phases. Furthermore, there 
was no break between the acquisition and extinction phases. 
The acquisition phase consisted of 24 trials (6 CS+ paired, 6 CS+ unpaired, 
12 CS-). The regular exposure extinction phases consisted of 32 trials each (16 CS+ 
unpaired, 16 CS-) and the extended exposure extinction phases consisted of 48 
trials each (24 CS+ unpaired, 24 CS-) (see Figure 1). In the regular and extended 
exposure extinction phases, early is defined as the first 8 CS+/CS- trials, and late is 
defined as the last 8 CS+/CS- trials.  
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Experimental trials were pseudo-randomised such that the first trial of 
acquisition was always paired and then after all trial types were randomly presented. 
The coloured squares were presented for a total of 4000 ms. The aversive sound 
lasted for 1000 ms, which subsided with the offset of the reinforced CS+’s. 
Subsequently, a blank screen was presented for 6000 – 8800 ms (Morriss, Saldarini, 
Chapman, Pollard, & van Reekum, 2018; Morriss & van Reekum, 2018). 
Blocks of trials in acquisition consisted of 12 trials and in extinction consisted 
of 16 trials. At the end of each block, participants were asked to rate how much they 
expected the blue square and yellow square to be followed by the sound stimulus, 
where the scale ranged from 1 (“Don’t Expect”) to 9 (“Do Expect”).  
Two other 9-point Likert scales were presented at the end of the experiment 
on the first day. Participants were asked to rate: (1) the valence and (2) arousal of 
the sound stimulus. The scales ranged from 1 (Valence: very negative; Arousal: 
calm) to 9 (Valence: very positive; Arousal: excited).  
 
Questionnaires 
To assess IU and trait anxiety, we administered the Intolerance of Uncertainty Scale 
(Freeston et al., 1994) and STICSA questionnaires (Ree, French, MacLeod, & 
Locke, 2008).  The IU measure consisted of 27 items that are rated on a 5-point 
Likert scale. The STICSA consisted of 21 items that are rated on a 4-point Likert 
scale.  
 
Rating scoring  
Rating data were reduced for each participant by calculating their average responses 
for each experimental condition (Acquisition CS+; Acquisition CS-; SDE CS+ Early; 
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SDE CS- Early; SDE CS+ Late; SDE CS- Late; NDE CS+ Early; NDE CS- Early; 
NDE CS+ Late; NDE CS- Late) using the E-Data Aid tool in E-Prime (Psychology 
Software Tools Ltd, Pittsburgh, PA). 
 
Skin conductance acquisition and scoring  
Physiological recordings were obtained using AD Instruments (AD Instruments Ltd, 
Chalgrove, Oxfordshire) hardware and software. Electrodermal activity was 
measured with dry MLT116F silver/silver chloride bipolar finger electrodes that were 
attached to the distal phalanges of the index and middle fingers of the left hand. A 
low constant-voltage AC excitation of 22 mVrms at 75 Hz was passed through the 
electrodes, which were connected to a ML116 GSR Amp, and converted to DC 
before being digitized and stored. An ML138 Bio Amp connected to an ML870 
PowerLab Unit Model 8/30 amplified the skin conductance signal, which was 
digitized through a 16-bit A/D converter at 1000 Hz. The electrodermal signal was 
converted from volts to microSiemens using AD Instruments software (AD 
Instruments Ltd, Chalgrove, Oxfordshire). 
Skin conductance responses were marked using ADinstruments software (AD 
Instruments Ltd, Chalgrove, Oxfordshire) and extracted using Matlab R2017a 
software (The MathWorks, Inc., Natick, Massachusetts, United States). CS+ 
unpaired and CS- trials were included in the analysis, but CS+ paired trials were 
discarded to avoid sound confounds. Skin conductance responses (SCR) were 
scored when there is an increase of skin conductance level exceeding 0.03 
microSiemens (Dawson, Schell, & Filion, 2000). The amplitude of each response 
was scored as the difference between the onset and the maximum deflection prior to 
the signal flattening out or decreasing. SCR onsets and respective peaks were 
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counted if the SCR onset was within 0.5-3.5 seconds (CS response) following CS 
onset (Morriss, Chapman, Tomlinson, & Van Reekum, 2018). Trials with no 
discernible SCRs were scored as zero. SCR magnitudes were square root 
transformed to reduce skew and z-scored (across conditions and phases) within-
subject to control for interindividual differences in skin conductance responsiveness 
(Ben‐Shakhar, 1985). SCR magnitudes were calculated by averaging SCR-
transformed values for each condition (Acquisition CS+; Acquisition CS-; SDE CS+ 
Early; SDE CS- Early; SDE CS+ Late; SDE CS- Late; NDE CS+ Early; NDE CS- 
Early; NDE CS+ Late; NDE CS- Late). We defined non-responders as those who 
responded to 10% or less of the CS+ unpaired and CS- trials (Morriss, Chapman, et 
al., 2018; Xia, Dymond, Lloyd, & Vervliet, 2017). Non-responders were excluded 
from the SCR analyses. 
 
Pupil dilation acquisition and scoring  
Eye movements were recorded using an Eyelink II eye-tracker with a sampling rate 
of 250 Hz (SR Research). Head movements were constrained with a chin-rest at a 
viewing distance of 60 cm. The eyetracker was calibrated using a standard 3 point 
grid at the start of the experiment. 
 Pupil dilation was extracted using Matlab R2017a software (The MathWorks, 
Inc., Natick, Massachusetts, United States). CS+ unpaired and CS- trials were 
included in the analysis, but CS+ paired trials were discarded to avoid sound 
confounds. Blink and saccade artifacts were identified using the associated Eyelink II 
markers and removed from the pupil dilation data. Pupil dilation was averaged for 
each 1000 ms window following CS onset, resulting in four windows of 1000 ms 
each. These data were baseline corrected by subtracting 1000 ms preceding each 
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CS onset from a blank screen (Lonsdorf et al., 2017). Following this pupil dilation 
data were z-scored (across conditions and phases) within-subject to control for 
interindividual differences in pupil dilation size (Leuchs, Schneider, & Spoormaker, 
2019). Trials were averaged per stimulus type, time and second window for each 
participant resulting in the following conditions (Acquisition CS+; Acquisition CS-; 
SDE CS+ Early; SDE CS- Early; SDE CS+ Late; SDE CS- Late; NDE CS+ Early; 
NDE CS- Early; NDE CS+ Late; NDE CS- Late).  
 
Ratings, SCR magnitude and pupil dilation analysis 
The analysis was conducted using the mixed procedure in SPSS 25.0 (SPSS, 
Inc; Chicago, Illinois). We conducted separate MLMs expectancy ratings, SCR 
magnitude and pupil dilation during acquisition, SDE and NDE. For expectancy 
ratings and SCR magnitude during the acquisition phase we entered Condition 
(Regular Exposure, Extended Exposure) and Stimulus (CS+, CS-) at level 1 and 
individual subjects at level 2. For expectancy ratings and SCR magnitude during 
SDE and NDE we entered Condition (Regular Exposure, Extended Exposure), 
Stimulus (CS+, CS-) and Time (Early: first 8 CS+/CS- trials, Late: last 8 CS+/CS- 
trials) at level 1 and individual subjects at level 2. For pupil dilation an additional 
factor of Second (1,2,3,4) was included in the MLMs.  
We included the following individual difference predictor variables into all of 
the multilevel models: IU and STICSA. In all models, we used a diagonal covariance 
matrix for level 1. Random effects include a random intercept for each individual 
subject, where a variance components covariance structure was used. Fixed effects 
include Condition, Stimulus, Time and Second. We used a maximum likelihood 
estimator for the multilevel models and corrected post-hoc tests for multiple 
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comparisons using the Benjamini-Hochberg False Discovery Rate procedure 
(Benjamini & Hochberg, 1995). Acceptable values for multiple comparisons had to 
be below the following: Acquisition rating, p < .016; Acquisition SCR, p < .016; 
Acquisition pupil dilation, p < .007; SDE rating, p < .021; SDE SCR, p < .014; SDE 
pupil dilation, p < .006; NDE rating, p < .028; NDE SCR, p < .021; NDE pupil dilation, 
p < .003. Pairwise comparisons were used only to follow up significant 2-way 
interactions. In the case of a three-way interaction with IU or STICSA, pairwise 
comparisons were examined from a 2-way interaction.  
In the MLMs two continuous predictor variables were entered (IU, STICSA), a 
significant interaction with one variable but not the other suggests specificity. Based 
on our prior work, we expected specificity for IU, but we explored interactions with 
STICSA, given extant findings with trait anxiety in the conditioning literature 
(Lonsdorf & Merz, 2017). Where a significant interaction was observed with IU or 
STICSA, we performed follow-up pairwise comparisons on the estimated marginal 
means of the relevant conditions estimated at specific IU values of + or -1 SD of 
mean IU, adjusted for STICSA (or IU). Similar analyses have been published 
elsewhere (Morriss, Macdonald, & van Reekum, 2016; Morriss, McSorley, & van 
Reekum, 2017).  
We conducted MLMs on SCR magnitude and pupil dilation to check that the 
middle trials (17-32) for the extended exposure condition and the last trials of the 
regular exposure condition (17-32) were comparable during SDE. For this analysis, 
we entered Condition (Regular Exposure, Extended Exposure), Stimulus (CS+, CS-) 
and Trial (16 trials for CS+ and CS- (last 8 CS+/CS- for Regular Exposure, middle 8 
CS+/CS- for Extended Exposure) at level 1 and individual subjects at level 2. 
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We included additional MLMs to assess SCR magnitude and pupil dilation 
across trials during SDE and NDE. We entered Condition (Regular Exposure, 
Extended Exposure), Stimulus (CS+, CS-) and Trial (16 trials for CS+ and CS- (first 
8, last 8)) at level 1 and individual subjects at level 2. 
 
Results 
For descriptive statistics see Table 1. 
Questionnaires 
The self-reported anxiety measures were normally distributed and had good internal 
reliability (see Figure 2): IU (M = 65.79, SD = 20.12, range= 32-125, α = .94); 
STICSA (M = 40.59, SD = 9.58, range = 22-69, α = .87). IU was positively 
significantly correlated with STICSA, r(142) = .682, p < .001. The regular and 
extended conditions had a similar range of scores for the IU and STICSA measures 
(Regular IU: M = 65.59, SD = 20.33; Extended IU: M = 66.02, SD = 20.02; Regular 
STICSA: M =  39.36, SD = 9.47; Extended STICSA: M = 41.95, SD = 9.59). 
 The regular and extended conditions also had a similar range of scores for the 
shortened version of the Intolerance of Uncertainty Scale (IUS-12: Carleton, Norton 
& Asmundson, 2007) and the Prospective and Inhibitory Intolerance of Uncertainty 
(P-IU, I-IU) subscales (Regular IUS-12: M = 29.55, SD = 8.50; Extended IUS-12: M = 
31.29, SD = 10.08; Regular P-IU: M =  18.89, SD = 5.39; Extended P-IU: M = 20.44, 






The sound stimulus was rated as aversive (M = 2.44 SD = 1,17 range 1-5, where 1 = 
very negative and 9 = very positive) and arousing (M = 6.65, SD = 1.56, range where 
1 = calm and 9 = excited). No significant differences between the regular exposure 
condition and extended exposure condition were found for the valence and arousal 
ratings of the sound, p’s > .4. 
Higher expectancy ratings of the sound with the CS+ versus CS- was found 
during acquisition [Stimulus, F(1, 143) = 938.011, p < .001, see Table 1 and Figure 
3A]. No other significant main effects of Condition or interactions with STICSA or IU 
were found for the expectancy ratings during acquisition, max F = 3.358. 
During SDE, participants displayed higher expectancy ratings of the sound 
with the CS+ versus CS-, p < .001. Expectancy ratings of the sound with the CS+ 
dropped over time, ps < .001 [Stimulus, F(1, 334.025) = 267.902, p < .001; Time, 
F(1, 334.025) = 44.012, p < .001; Stimulus x Time, F(1, 334.025) = 19.880, p < .001]. 
No other significant main effects of Condition or interactions with STICSA or IU were 
found for the expectancy ratings during SDE, max F = 1.524. 
A similar pattern was observed during NDE, whereby participants displayed 
higher expectancy ratings of the sound with the CS+ versus CS-, p < .001. 
Expectancy ratings of the sound with the CS+ and CS- dropped over time, ps < .001 
[Stimulus, F(1, 289.705) = 119.682, p < .001; Time, F(1, 289.705) = 31.836, p < 
.001; Stimulus x Time, F(1, 289.705) = 4.872, p = .028]. During NDE, expectancy 
ratings were higher overall for the regular exposure condition (M = 2.57, SD = 1.38) 
compared to the extended exposure condition (M = 1.99, SD = 1.39), p = .015 
[Condition, F(1, 152.357) = 5.998, p = .015].  
Individual differences in IU were related to expectancy ratings during NDE 
[Condition x Time x IU, F(1, 289.705) = 4.056, p = .045; see Figure 4]. This 
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significant interaction for expectancy ratings suggested that individuals with lower 
and higher IU benefited from extended exposure, relative to their counterparts in the 
regular exposure condition. Expectancy ratings were smaller for both CS+ and CS- 
across early to late NDE for Individuals with lower IU in the regular exposure 
condition, p =.357, whilst expectancy ratings to the CS+ and CS- dropped further 
across early to late NDE for Individuals with lower IU in the extended exposure 
condition, p < .001. Expectancy ratings to the CS+ and CS- were larger in early vs. 
late NDE for individuals with higher IU in the regular exposure condition, p < .001, 
whilst expectancy ratings were smaller to the CS+ and CS- during early and late 
NDE for Individuals with higher IU in the extended exposure condition, p = .231. No 
other significant main effects of Condition or interactions with STICSA or IU were 
found for the expectancy ratings during NDE, max F = 1.751. 
 
SCR 
SCR was significantly higher to the CS+ vs. CS- during acquisition [Stimulus, 
F(1,129) = 37.455, p < .001; see Table 1 and Figure 3B]. No other significant main 
effects of Condition or interactions with STICSA or IU were observed for SCR during 
acquisition, max F = 894. 
 During SDE, SCR was higher to the CS+ versus CS-, p < .001. In addition, 
SCR to both the CS+ and CS- dropped over time, p = .003 [Stimulus, F(1, 491.582) 
= 29.260, p < .001; Time, F(1, 491.582) = 8.610, p < .001]. The interaction between 
Condition x Stimulus x IU was not significant [Condition x Stimulus x Time x IU, F(1, 
491.582) = 2.990, p = .084].  
Individual differences in STICSA were related to SCR during SDE [Condition x 
Time x STICSA, F(1, 491.582) = 5.220, p = .023; see Figure 5]. Participants with 
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lower STICSA scores in the extended exposure condition showed a significant 
reduction in SCR response from early to late SDE, p = .005, whilst all other condition 
and STICSA combinations showed no reduction in SCR from early to late SDE, ps > 
.05. No other significant main effects of Condition or interactions with STICSA or IU 
were found for SCR during SDE, max F = 3.745. 
During NDE, SCR was higher to the CS+ versus CS- during early extinction, p 
< .001, but no difference was observed for the CS+ and CS- during late extinction p 
= .073 [Stimulus, F(1, 447.028) = 29.794, p < .001; Time, F(1, 447.028) = 51.149, p 
< .001; Stimulus x Time, F(1, 447.028) = 9.072, p = .003].  
Individual differences in STICSA were related to SCR during NDE [Condition 
x Time x STICSA, F(1, 447.028) = 4.428, p = .036: see Figure 5]. Participants with 
higher STICSA scores in the extended exposure condition had lower SCR response 
during the early and late parts of the NDE phase, p > .05, whilst all other condition 
and STICSA combinations showed a reduction in SCR from early to late NDE, ps < 
.005. 
 No other significant main effects of Condition or interactions with STICSA or 
IU were found for SCR during NDE, max F = 1.803. 
  
Pupil dilation 
During acquisition, no significant main effect of stimulus was observed for pupil 
dilation [Stimulus, F(1, 607.862) = 1.437, p = .231].  
Pupil dilation was significantly larger to the CS+ vs. CS- during SDE 
[Stimulus, F(1, 2047.009) = 27.420, p < .001; see Table 1 and Figure 3C]. Additional 
interactions with STICSA were observed for pupil dilation during SDE [Condition x 
Stimulus x STICSA, F(1, 2047.009) = 4.786, p = .029; Condition x Time x STICSA, 
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F(1,2047.009) = 7.356, p = .007]. Participants with higher STICSA scores in the 
regular exposure condition had larger pupil dilation to the CS+ vs. CS- during SDE, p 
< .001 (see Figure 6). All other condition and STICSA combinations showed smaller 
pupil dilation differentiation between CS+ and CS-, p’s above the threshold for 
multiple comparisons (p = .003). In addition, for the extended exposure condition 
lower STICSA was associated with reduced pupil dilation across early (M = .025, SD 
= 0.33) to late (M = -.106, SD = 0.34) SDE, p = .007, whilst higher STICSA was 
associated with an increased pupil dilation across early (M = -.052, SD = 0.28)  to 
late (M = .079, SD = 0.28), p = .004. However, these effects were just above the 
threshold for multiple comparisons (p = .003). No significant differences for STICSA 
in the regular exposure condition was observed for pupil dilation across early to late 
SDE, p’s > .05. 
Pupil dilation was significantly larger to the CS+ vs. CS- during NDE 
[Stimulus, F(1,2072.327) = 7.543, p = .006; see Table 1 and Figure 3C]. During 
NDE, pupil dilation significantly dropped across early (M = .041, SD = 0.18) to late 
(M = -.037, SD = 0.16) extinction for the regular condition, p = .005, but remained 
lower for early (M = .007, SD = 0.15) and late (M = .017, SD = 0.16) extinction for the 
extended exposure condition, p = .731 [Condition x Time , F(1,2072.327) = 6.924, p 
= .009].  
During each experimental phase, pupil dilation was greatest at 1 second post 
stimulus onset and smallest at 2 seconds post stimulus onset [Acquisition, Second, 
F(1, 432.306) = 164.374, p < .001; SDE, Second F(1, 1043.920) = 310.082, p < .001; 
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NDE, Second F(1, 1026.885) = 308.076, p < .001]. No other significant main effects 
of Condition, Time, or interactions with IU or STICSA were found, max F = 2.3091. 
 
Preregistered manipulation check 
We conducted MLMs on SCR magnitude and pupil dilation to check that the middle 
trials (17-32) for the extended exposure condition and the last trials of the regular 
exposure condition (17-32) were comparable during SDE. A significant interaction 
between Condition and Trial for pupil dilation was observed during SDE, where 
larger pupil dilation was found for the first trial for the extended exposure condition 
vs. the regular exposure condition [Condition x Trial, F(1, 529.759) = 1.938, p = 
.018]. No other significant main effects or interactions between Stimulus, Trial and 
Condition were observed for SCR and pupil dilation during SDE, Max F = 1.662. 
These results suggest that the late trials from the regular exposure condition and 
middle trials from the extended exposure condition were comparable.  
 
Preregistered analyses by trial 
We included additional MLMs to assess SCR magnitude and pupil dilation across 
trials during SDE and NDE. A significant interaction between Condition and Trial for 
pupil dilation was observed during NDE, where larger pupil dilation was found for the 
first two trials for the regular exposure condition vs. the extended exposure condition 
[Condition x Trial, F(1, 444.448) = 1.898, p = .022]. No other significant main effects 
 
1 Additional interactions with IU were observed for pupil dilation during NDE 
[Condition x Stimulus x IU, F(1,2072.327) = 4.023, p = .045; Condition x Stimulus x 
Time x IU, F(1,2072.327) = 4.266, p = .039]. However, these interactions were not 
significant when IU was entered into the model alone, suggesting these results as 
potentially spurious [Condition x Stimulus x IU, F(1,2049.829) = 1.135, p = .287; 
Condition x Stimulus x Time x IU, F(1,2049.829) = .771, p = .380].   
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or interactions between Trial, Stimulus and Condition were observed for SDE or 
NDE, Max F = 1.680.  
 
Additional preregistered exploratory analyses with the IUS-12 and its 
subscales  
To examine whether safety-learning and -retention were related to the IUS-12, P-IU 
and I-IU scales, we conducted further exploratory analyses. We created the following 
difference scores for each measure (ratings, SCR and pupil dilation): [Acquisition 
CS+ - CS-], [SDE early CS+ - CS-], [SDE late CS+ - CS-], [SDE early CS+ - CS- - 
SDE late CS+ - CS-], [NDE early CS+ - CS-], [NDE late CS+ - CS-], [NDE early CS+ 
- CS- - SDE late CS+ - CS-]. We examined whether the difference scores were 
correlated with the IUS-12, P-IU, and I-IU by Condition (Regular, Extended).  
To assess specificity between Condition, we tested the significance of the 
difference between the two correlation coefficients i.e. a correlation for regular 
exposure vs. extended exposure. Then, to assess specificity of the relevant IUS 
measure over STICSA, we conducted partial correlations and tested the significance 
of the difference between the two partial correlation coefficients. We only report the 
effects that survive the test of significant difference between the two Condition 
(Regular, Extended) correlation coefficients. 
There was a significant correlation between the SCR difference score (NDE 
early CS+ - CS- - SDE late CS+ - CS-) and I-IU in the regular exposure condition, 
r(61) = .322, p = .01 but not for extended exposure condition, r(55) = -.235, p > .05. 
The difference between the correlations for the regular and extended exposure 
conditions was significant, z = 3.06, p = .002. Moreover, when controlling for 
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STICSA, the difference between the partial correlations for the regular and extended 
exposure conditions remained significant, z = 3.05, p = .002. 
The effect above was driven by differences in SCR during the early part of 
NDE, as there was also significant correlation between the SCR difference score 
(NDE early CS+ - CS-) and I-IU in the regular exposure condition, r(61) = .297, p = 
.018  but not for extended exposure condition, r(55) = -.146, p > .05. The difference 
between the correlations for the regular and extended exposure conditions was 
significant, z = 2.42, p = .015. Again, when controlling for STICSA, the difference 
between the partial correlations for the regular and extended exposure conditions 
remained significant, z = 2.4, p = .0162. In sum, higher I-IU scores were associated 
with greater SCR response during the early part of NDE in the regular exposure 
condition, compared to the extended exposure condition (see Fig 7).  
No other significant correlations were observed between any of the measures 
and the IUS-12, P-IU, and I-IU during acquisition, SDE and NDE, p’s > .05. 
 
Discussion 
Here we examined the effect of self-reported IU and exposure experience on safety-
learning and -retention. We failed to replicate previous work showing that IU is 
associated with poorer safety-learning indexed via SCR. We found preliminary 
evidence for promoted safety-retention in individuals with higher Inhibitory IU who 
underwent extended exposure, relative to individuals with higher Inhibitory IU who 
 
2 We decided to do correlational analyses rather than MLMs because of the number 
of tests required for each dependent variable and phase of the experiment i.e MLMs 
with IUS-12 and each subscale alone, as well as with STICSA included. A similar 
result was found for SCR magnitude during NDE when I-IU was entered alone into 
the MLM [Condition x Stimulus x Time x I-IU, F(1,442.225) = 10.435, p = .001] and 
with STICSA included in the MLM [Condition x Stimulus x Time x I-IU, F(1,452.236) 
= 10.319, p = .001].  
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underwent regular exposure, indexed via SCR. These findings further our current 
understanding of the role of IU in safety-learning and -retention, informing models of 
IU and exposure-based treatments.  
 We observed typical patterns of conditioning in the acquisition, SDE and NDE 
phases: SCR magnitude and expectancy ratings were higher for the learned threat 
vs. safety cues. There was no significant reduction in responding to the learned 
threat vs. safety cues across the SDE phase for SCR magnitude, pupil dilation and 
expectancy ratings. However, we observed a reduction in responding to the learned 
threat vs. safety cues across the NDE phase for SCR magnitude and expectancy 
ratings. The absence of safety-learning across SDE may have occurred because a 
partial reinforcement schedule was used during the acquisition phase, which is 
known to prolong conditioning (Grady et al., 2016; Leonard, 1975).  
We observed no significant differences between the extended exposure 
condition vs. regular exposure condition during SDE on any of the measures. 
However, the extended exposure condition vs. the regular exposure condition 
showed lower pupil dilation and expectancy ratings overall during NDE. Such 
findings suggest that exposure length may not impact safety-learning directly after an 
aversive event but may inhibit anxious behaviours the next day i.e. generally reduce 
arousal and expectancy of threat. Our findings are at odds with previous research, 
which has shown that more trials versus fewer trials during SDE results in greater 
safety-learning, indexed via reduced startle blink magnitude and expectancy ratings 
(Golkar et al., 2013; Prenoveau, Craske, Liao, & Ornitz, 2013). Unfortunately, only a 
few human studies have examined trial number during SDE (Golkar et al., 2013; 
Prenoveau et al., 2013), and as far as we are aware no human studies have 
examined the impact of trial number of SDE upon NDE. The findings from the current 
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study provide some preliminary evidence that extended exposure may be beneficial, 
but also highlight that further work is needed in order to understand how exposure 
length impacts safety-learning and -retention mechanisms.  
Past research has shown that higher IU is associated with reduced safety-
learning, indexed by greater SCR, greater corrugator supercilii activity and pupil 
dilation to cues that no longer signal threat during the late part of SDE (Morriss, 
2019; Morriss et al., 2015; Morriss, Christakou, et al., 2016; Morriss et al., 2019; 
Morriss & van Reekum, 2019). Whilst effects of IU during SDE on SCR have been 
replicated many times (6 out of 7 experiments), in the current experiment it failed.  
Based on prior experiments (Dunsmoor et al., 2015; Lucas et al., 2018), we 
hypothesised that during NDE higher IU would be associated with poorer safety-
retention in the regular exposure condition vs. the extended exposure condition. We 
did not observe significant differences in safety-retention based on IU and exposure 
condition for SCR and pupil dilation. For expectancy ratings, we found individuals 
with higher IU in the regular exposure condition displayed greater expectancy ratings 
of the sound with both the CS+ and CS- during early vs. late NDE. In comparison, 
individuals with higher IU in the extended exposure condition and lower IU in both 
the regular and extended exposure conditions had lower expectancy ratings of the 
sound with both the CS+ and CS- throughout NDE.  
The lack of effects with the full 27 item IU scale during SDE and NDE may 
have occurred for a number of reasons. Firstly, in previous studies, IU has been 
used against other measures of self-reported anxiety (trait anxiety and worry) and 
not STICSA, which has been shown as a purer measure of self-reported anxiety 
(Grös et al., 2007). Secondly, whilst the distribution of IU and STICSA were similar in 
the regular and extended exposure conditions, other individual differences factors 
26 
 
that were not controlled for may have influenced the results (Lonsdorf & Merz, 2017) 
i.e. biological sex, use of contraceptive, use of anxiolytic medications and prior 
mental health history.  
Recent IU research typically relies on the 12 item IU scale and its subscales 
(Prospective: anticipation of uncertain threat; Inhibitory: paralysis under uncertainty), 
over the full 27 item scale, given its consistent and robust psychometrics (Carleton, 
Norton, & Asmundson, 2007; Hong & Lee, 2015; Khawaja & Yu, 2010). Therefore, 
we conducted preregistered exploratory analyses with the IUS-12 and its subscales. 
No significant associations were found between extinction learning metrics and the 
the IUS-12 total score or Prospective IU subscale.  However, higher Inhibitory IU in 
the regular exposure condition, relative to higher Inhibitory IU in the extended 
exposure condition, was associated with poorer safety-retention during early NDE, 
indexed via SCR. Moreover, this association during early NDE was specific to 
Inhibitory IU over STICSA. Notably, this result with Inhibitory IU is in line with 
previous work showing that higher IU is associated with poorer safety-retention 
during the start of NDE (Dunsmoor et al., 2015) and reinstatement (Lucas et al., 
2018). However, the specificity of IU or its subscales was not examined in past work 
and therefore it is not known whether these findings were driven by the inhibitory 
component of IU. Nonetheless, the current study highlights that individuals with 
higher Inhibitory IU may benefit from extended exposure. Interestingly, Inhibitory IU 
is uniquely associated with symptoms in a number of disorders that rely on exposure 
therapy, such as social phobia, panic disorder, agoraphobia and post-traumatic 
stress disorder (Fetzner, Horswill, Boelen, & Carleton, 2013; Mahoney & McEvoy, 
2012; McEvoy & Mahoney, 2011, 2012). It will be important therefore to replicate the 
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effect of Inhibitory IU on NDE, as such work may have relevance for understanding 
the  role of Inhibitory IU in exposure-based treatments (Knowles & Olatunji, 2018). 
Unexpectedly, we found additional results with the STICSA measure. Higher 
STICSA scores in the regular exposure condition was associated with larger pupil 
dilation to the learned threat vs. safety cues during SDE. All other condition and 
STICSA combinations showed no pupil dilation differentiation between the learned 
threat and safety cues during SDE. Furthermore, STICSA was associated with 
changes in SCR generally across SDE and NDE. We would have expected 
specificity of IU, over STICSA. In previous safety-learning research, IU has shown 
specificity over self-reported trait anxiety and worry (Morriss, Macdonald, et al., 
2016; Morriss & van Reekum, 2019). However, these results suggest that STICSA 
may be more closely aligned to safety-learning and -retention than trait anxiety and 
worry. Further replication of STICSA effects on safety-learning and -retention are 
needed to assess its importance on these mechanisms and specificity over IU.    
In conclusion, the results from this study provide some insight into how IU and 
exposure experience impact safety-learning and -retention. Tentatively, these results 
suggest that individuals with higher Inhibitory IU may benefit from extended 
exposure. Further experimental and clinical research is needed to assess how 
exposure experience can promote safety-learning  and -retention in individuals with 
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Figure 1. Image displaying experimental conditions and procedure.  
 
Figure 2. Histograms of IU and STICSA self-report measures by condition. 
 
Figure 3. Bar graphs depicting mean expectancy ratings (A), SCR magnitude (B) and 
pupil dilation (C) for each condition and stimulus type during each experimental 
phase. Error bars represent standard error. Expectancy ratings, 1 = Don’t expect, 9 = 
Do expect. Square root transformed and z-transformed SCR magnitude (μS), skin 
conductance magnitude measured in microSiemens. Z-scored pupil dilation and 
measured in ∆mm. 
 
Figure 4. Bar graphs depicting IU estimated at + or - 1 SD of the mean (controlling 
for STICSA) by condition and time for expectancy ratings during next-day extinction. 
Expectancy ratings were higher in early vs. late NDE for individuals with higher IU in 
the regular exposure condition, whilst expectancy ratings were smaller during early 
and late NDE for individuals with lower and higher IU in all other conditions. Error 
bars represent standard error. Expectancy ratings, 1 = Don’t expect, 9 = Do expect. 
 
Figure 5. Bar graphs showing STICSA estimated at + or - 1 SD of the mean 
(controlling for IU) by condition and time for SCR during same-day extinction and 
next-day extinction. Lower STICSA scores in the extended exposure condition was 
associated with a reduction in SCR response from early to late SDE, whilst all other 
condition and STICSA combinations showed no reduction in SCR from early to late 
SDE. Higher STICSA scores in the extended exposure condition had lower SCR 
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response during the early and late parts of the NDE phase, whilst all other condition 
and STICSA combinations showed a reduction in SCR from early to late NDE. Error 
bars represent standard error. Square root transformed and z-transformed SCR 
magnitude (μS), skin conductance magnitude measured in microSiemens.  
 
Figure 6. Bar graphs showing effects of STICSA estimated at + or - 1 SD of the 
mean (controlling for IU) by condition and stimulus for pupil dilation during same-day 
extinction. Higher STICSA scores in the regular exposure condition was associated 
with larger pupil dilation to the CS+ vs. CS- during SDE. All other condition and 
STICSA combinations showed smaller pupil dilation differentiation between CS+ and 
CS-. Error bars represent standard error. Z-scored pupil dilation and measured in 
∆mm. 
 
Figure 7. Scatter plots displaying correlations by condition between SCR magnitude 
CS+ - CS- difference scores and Inhibitory IU for early NDE. Positive difference 
scores indicate larger SCR magnitude to the CS+ vs. CS-. Higher Inhibitory IU was 
associated with larger SCR magnitude to the CS+ vs. CS- in the early part of NDE 
for the regular exposure condition, compared to the extended exposure condition. 
Square root transformed and z-transformed SCR magnitude (μS), skin conductance 
magnitude measured in microSiemens. 
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Table 1. Summary of means (SD) for each dependent measure as a function of condition (CS+ and CS-), separately for acquisition, early extinction and late 
extinction. 
Measure Day 1 Day 2 
  Acquisition Early Extinction Late Extinction Early Extinction Late Extinction 
  CS+ CS- CS+ CS- CS+ CS- CS+ CS- CS+ CS- 
Expectancy rating (1-9) 6.59 2.11 4.48 2.01 3.18 1.76 3.13 1.93 2.41 1.64 
  (1.41) (1.35) (2.26) (1.83) (2.04) (1.54) (1.99) (1.62) (1.75) (1.39) 
Square root transformed and z-scored SCR magnitude (√μs) 0.27 0.00 0.06 -0.10 -0.02 -0.15 0.21 0.00 -0.07 -0.13 
  (0.51) (0.30) (0.39) (0.30) (0.35) (0.39) (0.42) (0.32) (0.29) (0.36) 
Z-scored Pupil dilation (Δmm) 0.01 -0.01 0.03 -0.07 0.05 -0.02 0.04 0.01 0.02 -0.04 
  (0.55) (0.46) (0.31) (0.27) (0.32) (0.34) (0.36) (0.34) (0.34) (0.33) 
Note: SCR magnitude (√μS), square root transformed and z-scored skin conductance magnitude measured in microSiemens. Pupil dilation (Δmm), z-scored 
pupil dilation measured in delta millimetres. 
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